These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38150674)
21. COVID-19 reinfections in Mexico City: implications for public health. de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A Front Public Health; 2023; 11():1321283. PubMed ID: 38419814 [TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea. Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106 [TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 reinfections during the Delta and Omicron waves. Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527 [TBL] [Abstract][Full Text] [Related]
24. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province. Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X Front Public Health; 2023; 11():1256768. PubMed ID: 37780420 [TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis. Nguyen NN; Nguyen YN; Hoang VT; Million M; Gautret P Viruses; 2023 Apr; 15(4):. PubMed ID: 37112949 [TBL] [Abstract][Full Text] [Related]
26. Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population. Wei J; Stoesser N; Matthews PC; Khera T; Gethings O; Diamond I; Studley R; Taylor N; Peto TEA; Walker AS; Pouwels KB; Eyre DW; Nat Commun; 2024 Feb; 15(1):1008. PubMed ID: 38307854 [TBL] [Abstract][Full Text] [Related]
27. Reinfections with Different SARS-CoV-2 Omicron Subvariants, France. Nguyen NN; Houhamdi L; Delorme L; Colson P; Gautret P Emerg Infect Dis; 2022 Nov; 28(11):2341-2343. PubMed ID: 36150518 [TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil. Freire-Neto FP; Teixeira DG; da Cunha DCS; Morais IC; Tavares CPM; Gurgel GP; Medeiros SDN; Santos DCD; Sales AO; Jeronimo SMB PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010337. PubMed ID: 36191040 [TBL] [Abstract][Full Text] [Related]
29. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China. Yu W; Guo Y; Hu T; Liu Y; Fan Q; Guo L; Zheng B; Kong Y; Zhu H; Yu J; Chen S; Zhang Y; Wang J; Li F; Yang F; Wang Y; Zhu Y; Huang Y; Shen Z; Ruan Y; Mao R; Zhang J J Med Virol; 2023 Aug; 95(8):e28997. PubMed ID: 37537950 [TBL] [Abstract][Full Text] [Related]
30. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. COVID-19 Forecasting Team Lancet; 2023 Mar; 401(10379):833-842. PubMed ID: 36930674 [TBL] [Abstract][Full Text] [Related]
31. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants. Özüdoğru O; Bahçe YG; Acer Ö Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013 [TBL] [Abstract][Full Text] [Related]
32. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England. Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501 [TBL] [Abstract][Full Text] [Related]
33. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review. Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490 [TBL] [Abstract][Full Text] [Related]
34. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022. Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588 [TBL] [Abstract][Full Text] [Related]
35. Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection. Sočan M; Mrzel M; Prosenc K; Korva M; Avšič-Županc T; Poljak M; Lunar MM; Zupanič T Front Public Health; 2024; 12():1294261. PubMed ID: 38450129 [TBL] [Abstract][Full Text] [Related]
36. Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes. Mondi A; Mastrorosa I; Piselli P; Cimaglia C; Matusali G; Carletti F; Giannico G; Milozzi E; Biliotti E; Di Bari S; Chinello P; Beccacece A; Faraglia F; Vittozzi P; Mosti S; Tetaj N; Stazi GV; Pinnetti C; Camici M; D'Annunzio A; Marani A; Fabeni L; Specchiarello E; Gruber CEM; Villanacci A; Minicucci S; Garbuglia AR; Ianniello S; Marchioni L; Taglietti F; D'Offizi G; Palmieri F; Nicastri E; Maggi F; Vaia F; Girardi E; Antinori A J Med Virol; 2023 Jun; 95(6):e28831. PubMed ID: 37246793 [TBL] [Abstract][Full Text] [Related]
37. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States. Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023. Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671 [TBL] [Abstract][Full Text] [Related]
40. Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022. Foulkes S; Monk EJM; Sparkes D; Hettiarachchi N; Milligan ID; Munro K; Taylor-Kerr A; Platt N; Howells A; Kyaw JYA; Adaji E; Gallagher E; Khawam J; Wellington E; Price L; Crossman D; Norman C; de Lacy E; Cromey L; Corrigan D; Lackenby A; Barbero P; Elegunde B; Zambon M; Chand MA; Brown CS; Islam J; Atti A; Hopkins S; Hall VJ; Cole MJ; Emerg Infect Dis; 2023 Jan; 29(1):184-188. PubMed ID: 36454718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]